Cambridge Trust’s Equifax EFX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$11K Sell
41
-9
-18% -$2.29K ﹤0.01% 574
2023
Q4
$12.4K Hold
50
﹤0.01% 558
2023
Q3
$9.16K Hold
50
﹤0.01% 589
2023
Q2
$11.8K Hold
50
﹤0.01% 585
2023
Q1
$10.1K Sell
50
-14
-22% -$2.91K ﹤0.01% 626
2022
Q4
$12K Hold
64
﹤0.01% 612
2022
Q3
$11K Sell
64
-184
-74% -$36K ﹤0.01% 633
2022
Q2
$45K Sell
248
-134
-35% -$26.8K ﹤0.01% 492
2022
Q1
$91K Sell
382
-96
-20% -$22.6K ﹤0.01% 441
2021
Q4
$140K Buy
+478
New +$133K ﹤0.01% 386

Other funds holding EFX

Cambridge Trust's EFX Position: Q1 2024 in Review

Cambridge Trust reduced its Equifax (EFX) stake by 18% in Q1 2024, selling an estimated $2.29K and leaving 41 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #574.

Cambridge Trust first reported a position in EFX in Q4 2021 and has held it in 10 quarters since. The position peaked at $140K in Q4 2021. 768 funds tracked by Wall St. Rank hold EFX as of Q1 2024.

  • Cambridge Trust held 41 shares of Equifax worth $11K as of Q1 2024.
  • Cambridge Trust sold 9 Equifax shares in Q1 2024, an estimated $2.29K.
  • Equifax made up ﹤0.01% of Cambridge Trust's portfolio in Q1 2024, its #574 holding.
  • Cambridge Trust first reported a position in Equifax in Q4 2021 and has held it in 10 quarters since.
  • Cambridge Trust's Equifax position peaked at $140K in Q4 2021.
  • 768 funds tracked by Wall St. Rank held Equifax as of Q1 2024.

Based on Cambridge Trust's 13F filing for Q1 2024, filed 30 May 2024.